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A quantitative fluorescence labeled immunosorbent assay (FLISA) and qualitative on-
site column tests were developed for the determination of aflatoxin M1 (AfM1) in milk 
products. The use of quantum dots (QD) loaded liposomes as a label significantly increased 
the assay sensitivity by encapsulating multiple QD in a single liposome and, therefore, 
amplifying the analytical signal.  
Two different techniques were compared to obtain aflatoxin-protein conjugates, used 
for further coupling with the liposomes. The influence of non-specific interactions of the 
obtained liposomes-labeled conjugates with the surface of microtiter plates and column 
cartridges was evaluated and discussed. The limit of detection for FLISA was 0.014 µg kg
-1
. 
For qualitative on-site tests the cut-off was set at 0.05 µg kg
-1 
taking into account the EU 
maximum level for aflatoxin M1 in raw milk, heat-treated milk and milk for the manufacture 
of milk based product. The direct addition of labeled conjugate in the milk samples resulted in 
an additional decrease of analysis time. 
An intra-laboratory validation was performed with sterilized milk and cream samples 
artificially spiked with AfM1 at concentrations less, equal and more than the cut-off level. It 
was shown that milk products could be analyzed without any sample preparation, just diluted 
with the buffer. The rates for false positive and false negative results were below 5% (2.6% 
and 3.3%, respectively).  
Keywords: Liposomes; quantum dots; immunoassay; on-site method; fluorescent labeled 
immunoassay; aflatoxin M1. 
 
Introduction 
Concern about food safety requires the development of rapid and sensitive on-site tests 
suitable for non-laboratory application. This is especially important for perishable goods, as 
their short lifetime demands no-delay screening.  
One of the contaminants possibly present in food in very low concentrations is 
aflatoxin M1 (AfM1). Aflatoxins are highly toxic secondary metabolites of Aspergillus 
species. AfM1, the major metabolite of aflatoxin B1 (AfB1), generated by its hydroxylation in 
mammals and subsequently secreted in milk of lactating cows, is one of the most dangerous 
pollutants of milk and milk products. Both AfB1 and AfM1 are characterized with 
carcinogenic and hepatotoxic activity, so AfM1 has been classified by the International 
Agency for Research on Cancer (IARC) among other naturally occurring aflatoxins as 
possibly carcinogenic to humans  (Group 2B carcinogen) [1]. AfM1 is relatively stable during 
milk storage and thermal processing, as well as during production of various dairy products 
[2]. It makes AfM1 very dangerous for human health. The maximum limit (ML) of AfM1 in 
milk established by the US Food and Drug Administration (FDA) is 0.5 ng mL
-1 
[3]. This 
value for AfM1 in raw milk, heat-treated milk and milk for the manufacture of milk based 
products according to the European Commission Regulation was set at 0.05 µg kg
-1
 [4].  
There are a lot of published data, devoted to the contamination of milk and milk 
products with AfM1. For example Alborzi et al. [5] described 100% contamination of 
analyzed Iranian milk samples with AfM1, Rastogi et al. [6] found this mycotoxin in 87.3% 
of tested Indian milk products. Unusan et al. [7] mentioned that the level of AfM1 was above 
the EU maximum limit in 47% of analyzed milk samples. Very recently AfB1 contaminated 
feed was available on the EU market and fed to lactating cows [8]. Therefore, the problem of 
AfM1 occurrence in milk deserves a lot of scientific attention and need both laboratory and 
on-site methods development.  
A high performance liquid chromatography with fluorimetric detection coupled with a 
clean-up treatment by immunoaffinity columns (IC) is the reference method used for the 
determination of aflatoxins in milk [9]. But a great variety of rapid techniques for AfM1 
detection in milk were published [10]. Most of them were immunochemical tests based on 
highly specific antigen-antibody interactions. All published immunochemical techniques can 
be divided in instrumental methods and non-instrumental tests. Enzyme-linked 
immunosorbent assay (ELISA) [9,11-12], ultrasensitive chemiluminescent enzyme 
immunoassay [13], flow-injection immunoassay with amperometric detection [14] and 
different kinds of sensors [15-16] were described. ELISA was even included in ISO 
guidelines [17] and used for legal purposes (but it requires confirmation by a reference 
technique). These techniques are characterized with good analytical performances, but they 
are not suitable for on-site application.  
One of the most popular on-site formats applied for AfM1 determination is lateral-
flow immunoassay (LFIA). LFIA allows the determination of AfM1 with a visual detection 
limit of 0.3 ng mL
-1 
[18] and 1 ng mL
-1 
[11]. Several commercially available LFIA for AfM1 
determination in milk are appropriate for qualitative and semi-quantitative detection. 
However, LFIA often  cannot reach the expected sensitivity, according to the established EU 
ML (limit of detection  (LOD) of the R-Biopharm commercial test is 4 µg kg
-1
, LOD of the 
test produced by Charm Science inc is 0.5 µg kg
-1
, LOD of the test developed by Creative 
Diagnostics is 0.3 µg kg
-1
). To achieve this value some preliminary sample pretreatment is 
required (the tests from Romer Labs (LOD of 0.047 µg kg
-1
) or from Unisensor (LOD of 
0.050 µg kg
-1
)). This can be explained by the impossibility of LFIA to concentrate the target 
analyte. 
 
A gel-based column immunoassay allows the combination of purification, 
concentration and sensitive enzyme-based detection in one set-up. Goryacheva et al. [19] 
reached a cut-off level for AfM1 of 0.04 µg kg
-1
 because 10 mL of milk could be passed 
through the immunochemical column. The large volume allowed to pre-concentrate the 
analyte and to reach high sensitivity, but on the other hand, it gave rise to high matrix 
interference and needed a centrifugation step for milk defatting.  
The most popular labels for immunoassays are enzymes. They provide high 
sensitivity, but also could be one of the main reasons of false results due to the susceptibility 
of enzymes to matrix constituents. Besides, additional analysis steps such as washing and 
application of chromogenic substrate are necessary. Moreover, the enzymatic reaction is time-
dependent, and a strict compliance with the described assay protocol is important.  
Meanwhile, different kinds of particulate and nanosized labels were used for 
immunoassays e.g., colloidal gold, colloidal carbon, “colloidal dyes”, colloidal selenium, 
magnetic nanoparticles, lanthanides, dye entrapped polysterene, liposomes or latex  etc [20-
22]. Each of them has its own strengths and weaknesses.  
Quantum dots (QD) play now a significant role in biotechnological and bioanalytical 
research, due to their unique spectral properties such as intensive fluorescence, high 
photostability, tunable emission spectra, high-quantum yield and low photobleaching [23]. 
But transfer of water-insoluble QD into aqueous media usually results in decrease of 
luminescence yield [24]. However, they can be transferred into aqueous media after loading 
into liposomes with keeping their spectral characteristics [25].  
Liposomes are spherical lipid vesicles. The lipid molecules consist of hydrophilic and 
hydrophobic groups, so in aqueous solutions they semi-organize to increase the solubility. 
Due to their extensive internal volume liposomes can carry not one, but a high number of 
markers. Therefore liposomes were applied in immunoassay [26-28].  
The goal of this investigation was the development of a novel ultrasensitive 
immunochemical on-site test for AfM1 determination in milk based on luminescent 




Reagents and materials 
Lipoid S75 was purchased from Lipoid GMBH (Ludwigshafen, Germany). N-
hydroxysuccinimide (NHS), 3-(2-Pyridyldithio)propionic acid N-hydroxysuccinimide ester 
(SPDP), ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC), dithiothreitol (DTT),                                
O-(carboxymethyl)hydroxylamine hemihydrochloride (CMO), albumin from chicken egg 
white (OVA), bovine serum albumin (BSA), N,N-dimethylformamide (DMFA), Sephadex G-
75, 2-(N-Morpholino)ethanesulfonic acid (MES), EDTA tetrapotassium salt were purchased 
from Sigma-Aldrich (Bornem, Belgium). AfM1 was supplied by Fermentek (Jerusalem, 
Israel). Imject Cationized BSA (cBSA Immune Modulator) and protein concentrators (9K, 20 
mL) were purchased from Thermo Scientific (Rockford, USA). Anti-AFB1 (monoclonal) was 
obtained from Soft Flow Hungary Ltd (Pecs, Hungary). It was characterized with 79% cross-
reaction with aflatoxin M1, 33% with aflatoxin M2, 76% with AfB2, 55% with AfG1, 6% 
with AfG2 and none at all with AfB2a and AfG2a [29]. CNBr-activated sepharose 4B was 
purchased from GE Healthcare Bio-Sciences AB (Uppsala, Sweden). Plastic tubes (Bond Elut 
catridges, 1 mL) and polyethylene frits (1/4 in. diameter) were supplied by Varian Belgium 
NV/SA (Sint-Katelijne-Waver, Belgium). Microtiter plates (96 flat-bottom wells with high 
binding capacity; black Maxisorp) were purchased from Nunc A/S (Roskilde, Denmark). 
Certified reference material (CRM) – whole milk powder with an AfM1 certified value at 
111±0.018 µg kg
-1
 and 0.44±0.06 µg kg
-1
– was supplied by the Institute for Reference 
Materials and Measurements (European Commission, Joint Research Centre, Geel, Belgium). 
Milk products (milk, cream) were bought in Belgian supermarkets.   
Size distribution of the liposomes was measured by using the Zetasizer Nano ZS 
(Malvern, England). All measurements were carried out at 25 °C. 
Water-insoluble CdSe/3CdS/2ZnS core/shell/shell QD were synthesized by Elena S. 
Speranskaya and Valentina V. Goftman  (Saratov State University, Saratov, Russia). λex=380 
nm, λem=590 nm. 
 
Synthesis of AfB1-cBSA and AfM1-cBSA 
For aflatoxin-cBSA synthesis an adapted technique described by Zhou et al. was 
applied. [30]. The mycotoxin (~ 1 µmol) was dissolved in 1 mL of 0.1 M MES buffer (pH 
4.8, containing 100 µL of DMFA) and added dropwise to cBSA solution (0.025 µmol). 
Formaldehyde (150 µL)  was added. The mixture was gently stirred for 24 h at 37 °C. For 
removal of unbound low-molecular weight substances, protein concentrator tubes 20 mL/9K 
were used. Concentrations of the obtained conjugates were determined 
spectrophotometrically. AfB1-cBSA (0.7 mg mL
-1
) and AfM1-cBSA (0.6 mg mL
-1
) were kept 
at -18 °C. 
 
Synthesis of AfB1-OVA and AfM1-OVA 
Carboxymethoxylamine (CMO) was used to include carboxyl groups in AfB1 and 
AfM1. The AfB1-ovalbumin (AfB1-OVA) and AfM1-ovalbumin (AfM1-OVA) conjugates 
were synthesized according to the standard technique of N-hydroxysuccinimide/N,N'-
dicyclohexylcarbodiimide activation of hapten’s COOH-group. NHS (~2 µmol) and EDC (~2 
µmol) in DMFA were added dropwise to the obtained derivatised mycotoxins solution (~0.2 
µmol), and the reaction was kept for 2.5 h at RT under constant magnetic stirring. The 
activated derivate was mixed with the previously cooled OVA solution (~4 nmol) and kept 
for 2 h at RT under stirring followed by overnight incubation at 4 °C. 
The conjugates were dialyzed (3 days against PBS, at 4 °C, constant stirring). 
Concentrations of AfB1-OVA (0.3 mg mL
-1
) and AfM1-OVA (0.3 mg mL
-1
) were determined 
spectrophotometrically. The obtained conjugates were kept at -18 °C. 
 
Preparation of QDs-loaded liposomes (LQD) 
The preparation of LQD was based on the technique, described by Bangham et al. 
[31]. Lipoid S75 (94 µmol) and the water insoluble QDs (1 nmol) were dissolved in 1 mL of 
chloroform. The organic solvent was removed by rotary evaporation at 45 °C. Then, 6 mL of 
PBS were added to the dried lipids and the mixture was vigorously stirred in a water bath at 
45 °C for 30 min. The desired particle size was obtained by sonication (5 min). The liposomes 
suspension was centrifuged at 20 000 g for 15 min (RT °C) and the supernatant was removed. 
The pellet was re-dissolved in PBS and used for further experiments. The obtained LQD 
solution was stored at 4 °C. Prepared LQD were stored at 4 
◦
C and proved stable for at least 1 
month. 
 
Synthesis of liposome-labeled conjugate  
SPDP (1.8 mg in 300 µL of ethanol) was added dropwise to the analyte-protein 
conjugates (AfM1-OVA, AfB1-OVA, AfB1-cBSA, AfM1-cBSA; 2 μmol of conjugate in 2 
mL of 0.1 M sodium phosphate buffer, pH~7.5). The reaction mixtures were stirred during 30 
min at RT, and excess of the crosslinker was removed by application of the protein 
concentrator tubes (20 mL/9K). The residues were reconstituted in sodium acetate buffer 
(pH~4.5). For pyridine-2-thione release DTT (0.8 mg in 100 µL of acetate buffer) was added 
dropwise to the SPDP-modified protein conjugates and the reaction continued during 30 min 
under constant stirring at RT. Excess of DTT was removed by the protein concentrator tubes 
(20 mL/9K), and the modified conjugates were reconstituted in 0.05 M sodium phosphate 
buffer (containing 1 mM EDTA). 
For liposomes thiolation 300 µL of SPDP (2.5 μmol) were mixed with 2 mL of LQD. 
The reaction mixture was stirred during 2 h at RT, and excess of the crosslinker was removed 
by the protein concentrator tube. The vesicles were suspended in 0.05 M sodium phosphate 
buffer, containing 1 mM EDTA. 
Modified LQD (1.7 mL) was added dropwise to the thiolated analyte-protein 
conjugates. Reactions were performed under constant stirring overnight at RT. The modified 
liposomes were separated from excess protein by gel-filtration using Sephadex G-75 and kept 
at 4 °C. Prepared conjugates were stored at 4 ◦C and proved stable for at least 1 month. 
 
Microtiter plate fluorescence-labeled immunosorbent assay (FLISA)  
The 96-well opaque black microtiter plates were coated with anti-AfB1 antibody 
(dilution 1/50 000, 100 μL well
-1
) in coating buffer (0.05 M sodium carbonate buffer, pH~9.6, 
CBS) by an overnight incubation at 4 °C or for 2 h at 37 °C. Afterwards, the plates were 
washed three times with PBS containing 0.05% (v/v) Tween 20 (PBST) and blocked for 1 h at 
37 °C with PBS containing 2% casein (w/v). The plates were later washed two times with 
PBST. AfM1 standard solution in PBS or diluted milk sample (50 μL well
-1
) was added 
simultaneously with the LQD-labeled conjugate (dilution 1/50, 50 μL well
-1
). After 1 hour-
incubation the plates were washed four times with PBST. The content of each well was re-
dissolved in 100 μL of PBS. Luminescence was measured using the Envision 2104 Multilabel 
Plate Reader (Waltham 
Massachusetts, USA). 
The standard FLISA sigmoidal curve was plotted in a semi logarithmic scale: 
luminescence intensity or relative luminescence intensity (ratio of values of luminescence 
intensity measured at standard concentrations and zero concentration) against logarithm of 
analyte concentration. It is described by the Rodbard’s function:  
y = ( A – D ) / [ 1 + (x / C )
b
 ] + D 
А: maximum luminescence intensity value, D: minimum luminescence intensity value, b: slope of 
the curve in the IC50 plot, С: IС50 concentration of analyte. LOD was defined as three times the 
signal-to-noise ratio. 
 
Gel-based immunoassay (GBI) for on-site detection 
Sepharose 4B gel coupled with the anti-AfB1 antibody (9 μL of antibody for 0.5 g of 
Sepharose; coupled gel) and gel with blocked active groups (blocked gel) were prepared 
according to the standard procedure [32]. Mixture of coupled and blocked gels (200 µL) was 
placed between two polyethylene frits inside an empty 1-mL Bond Elut column. The column 
was kept at 4 C until use. Before analysis, the immunochemical columns were additionally 
blocked with 1% glycine (w/v) in 0.1 M hydrocarbonate buffer (pH~8). 
AfM1 standard solution (1mL) or diluted milk sample (1 mL) was passed through the 
column. After a washing step with 1 mL of PBS, 100 μL of labeled conjugate (diluted 1/50) 
were added and incubated for 6 min. Afterwards, excess of the conjugate was removed with 1 
mL of PBS. Visual detection was performed immediately after the washing step under a UV 
lamp (365 nm).  
 
Polyethylene frit-based immunoassay (FBI) for on-site detection 
The frit-based column immunoassay procedure was described in our previous 
publications [32,33]. First, polyethylene frits were degassed in ethanol by ultrasonication (15 
min). Then they were placed in 1 mL Bond Elut catridges, and 300 μL of ethanol/water 
(50/50, v/v), 300 μL of water and 600 μL of carbonate buffer were passed through the 
columns for further activation. The anti-AfB1 antibody (200 μL, diluted 1/30 000 in CBS) 
was immobilized directly onto the activated polyethylene frits and incubated for 20 min at 37 
°C. Excess of unbound antibody was removed, and the frits’ surface was blocked with PBS 
containing 3% casein (500 μL per frit, 15 min incubation, 37 °C). The further procedure was 
similar as described for the GBI.  
In another variant of this on-site test, the labeled conjugate was directly added in the 
milk sample prior to its analysis. This approach allowed to shorten the analysis procedure. In 
this case visual detection was realized immediately after the sample addition and washing 
step. PBS (2 mL) was used to remove excess of the unbound conjugate.  
 
Analytical performance of the column tests 
The cut-off level of the column tests was defined as the lowest AfM1 concentration 
which did not result in appearance of luminescence. Absence of luminescence of the test layer 
was considered as a positive result (analyte concentration at or above the cut-off level), 
presence of luminescence, independent on its brightness, as a negative sample (analyte 
concentration below the cut-off level). Samples with AfM1 concentrations higher (or lower) 
than the cut-off level, which resulted in negative results (or positive results) were considered 
to be false negative (or false positive), respectively. 
 
Sample preparation 
For milk and cream samples preparation, a fivefold dilution with PBS was used. Milk 
powder was suspended in distilled water and dissolved by stirring. For each milk sample, 




Result and discussion 
Preparation of LQD-labeled conjugates for AfM1 determination 
QD-loaded liposomes were prepared by thin-film evaporation using soybean lecithin 
derived material (Lipoid S75). This procedure consists in 2 steps: the formation of a 
phospholipids’ thin film and its hydratation for liposomes formation.  
In this work CdSe/3CdS/2ZnS core/shell/shell QDs were used. Uncovered CdSe 
nanocrystals are characterized with low quantum yield (QY) and they are not photostable [34, 
35]. The QY and photostability can be sufficiently improved by growing an inorganic shell of 
a wider band-gap semiconductor around the CdSe cores [34]. In this work, the SILAR 
technique was used to cover the CdSe cores with an inorganic ZnS shell. The initial CdSe 
core (λ(emission)=524 nm) has a QY of 1.5%, while after coating with CdS and ZnS layers 
the QY of QDs was sufficiently increased (~35%). 
As the molecular structures of AfB1 and AfM1 are similar and the difference is just in 
one hydroxyl group, it is more than possible that antibodies against AfM1 could be 
characterized with high cross-reactivity to AfB1, and vice versa, antibodies against AfB1 
could be sensitive to AfM1 too. Therefore both AfB1 and AfM1 were used to synthesize 
labeled conjugates for AfM1 determination. Neither AfB1, nor AfM1 contains active groups 
suitable for binding with proteins. Therefore, two different conjugation techniques were used 
to couple aflatoxin molecules with proteins. The first method was based on the synthesis of 
carboxymethoxylamine derivates of AfM1 and AfB1. The other approach was based on the 
Mannich reaction of the mycotoxin with cBSA and consisted of imidization of N-
hydroxymethyl amine groups of cBSA, enolation of aflatoxin and reaction when electrophilic 
iminium ionized BSA attacked the C-nucleophilic center of the enolated aflatoxin. Addition 
of formaldehyde in the reaction mixture was necessary, because it participates in cBSA 
imidization. The reaction was done in MES buffer (pH~4.8) since acidic conditions are 
important for ketone enolization.  
The prepared analyte-protein conjugates were used for coupling with QD-loaded 
liposomes. Lipoid S75 contains 7-10% (w/w) of phosphatidylethanolamine, which provides 
active amino-groups on the liposomes’ surface and stabilizes the obtained vesicles. Both 
analyte-protein conjugate and LQD were modified by SPDP, the heterobifunctional cross-
linker. Amino groups of LQD could react with SPDP and formed an amide bond. The 2-
pyridyldithiol end of SPDP participated in the formation of a disulfide linkage with sulfhydryl 
groups of other molecules. Therefore, after activation of the proteins and LQD with SPDP, 
they reacted and coupled with each other.  
 
Fluorescent labeled immunoassay for AfM1 determination 
Four synthesized conjugates (AfB1-cBSA-LQD, AfM1-cBSA-LQD, AfB1-OVA-
LQD, AfM1-OVA-LQD) were applied for AfM1 determination by FLISA. It was the 
objective to develop FLISA with a sensitivity close or lower than the maximum limit for 
AfM1 in milk and milk products, established by the European Commission. The envisaged 
sensitivity was reached through variation of antibody and labeled conjugate concentrations. 
The conjugates obtained via CMO-derivatives were characterized by a considerably stronger 
non-specific interaction with the microtiter plate, than the conjugates based on the binding 
with cBSA. To level this interaction a high casein concentration was used in the blocking 
solution (PBS-2% casein, w/v). It resulted in the suppression of luminescence intensity, and 
for amplification of the analytical signal the antibody concentration was increased. Thus, the 
sensitivities of AfM1 determination with AfB1-OVA-LQD (IC50 was 0.32 µg kg
-1
) and AfM1-
OVA-LQD (IC50 was 0.31 µg kg
-1
) were considerably lower, than the sensitivity of analysis 
based on AfM1-cBSA-LQD (IC50 was 0.015 µg kg
-1
) and AfB1-cBSA- LQD (IC50 was 0.014 
µg kg
-1
) (Fig. 1). For further experiments AfB1-cBSA-LQD was chosen. The reached LOD 
(0.0025 µg kg
-1
) allowed analyzing AfM1 in milk products. As the LOD was considerably 
lower than the EU ML for AfM1 in milk, it  allowed to use high dilution of milk samples. 
 
Column tests for AfM1 determination 
As carriers for antibody immobilization CNBr-activated sepharose gel and thin 
polyethylene frits were used. The targeted cut-off level was based on the EU ML for AfM1 in 
milk and milk products (0.05 µg kg
-1
). Bearing in mind the sample dilution (1/5 with PBS) the 
assay sensitivity should be around 0.01 µg kg
-1
. The analytical signal was registered by the 
naked eye, so the luminescence intensity should be high enough for unambiguous detection. 
At the same time the assay sensitivity should be high enough to reach the established ML. In 
the FBI the specific antibody was directly coated onto the frit surface; eight different antibody 
concentrations were compared (dilutions were from 1/500 to 1/30 000 in CBS). In the GBI, 
when the antibody was covalently bound with active CNBr-groups of sepharose, various 
dilutions of coupled gel with blocked gel were checked (from 1/10 to 1/75). Low antibody 
concentrations in the FBI (dilution higher than 1/30 000) or high gel dilutions in the GBI 
(higher than 1/50) showed a very low intensity of the analytical signal, that could cause false 
results during the analysis of real samples. As optimal conditions, an antibody dilution of 1/30 
000 for FBI and 1/50 gel dilution for GBI were chosen. The optimal  AfB1-cBSA-LQD 
dilution was 1/50.  
The optimal time for antibody coating in FBI was 20 min at 37 °C. Further incubation 
did not lead to an increased analytical signal, but a shorter coating time was not enough. 
Blocking in FBI was necessary to prevent undesirable physical absorption of the labeled 
conjugate on the frit’s surface. Thus, blocking was done with 3% casein-PBS (w/v) during 15 
min at 37 °C.  
PBS-Tween 20 (0.1% v/v) was used as washing buffer for conjugate dilution in both 
FBI and GBI. For additional blocking of the gel in GBI 1% glycine (w/v) in 0.1 M NaHCO3 
buffer (pH~8) was added in the already prepared immunocolumns, incubated during 10 min at 
room temperature and passed through. It was done to block unbound CNBr-groups of 
sepharose.  
To decrease the analysis time and simplify the analytical procedure the labeled 
conjugate was also directly added in the analyzed samples. This approach enabled to 
completely level the non-specific interaction of AfB1-cBSA-LQD with the polyethylene frit 
without using additional blocking with casein. It became possible because milk as a 
multicomponent mixture, which contains different proteins, acted as an additional blocking 
agent. But, the presence of this protein mixture decreased luminescence of the LQDs-labeled 
conjugate, so, the concentration of AfB1-cBSA-LQD had to be increased (in this case the 
optimal dilution of AfB1-cBSA-LQD was 1/40). For washing 5 ml of PBS were used to 
remove excess of unbound conjugate.  
The achieved cut-off value was 0.05 µg kg
-1
 in both formats with a visible and clear 
contrast in luminescence between positive and negative samples (Fig. 2).  
 
Validation of developed techniques 
FLISA validation was performed with milk and cream samples, artificially spiked with 
AfM1 at concentrations less, equal and more than the established ML for AfM1 in milk 
products. As a sample pretreatment a fivefold dilution of milk with PBS was used. LQD are 
less susceptible for the matrix content, than enzymes, and luminescence is easier to detect by 
the naked eye. The correlation between added amounts of AfM1 and found concentrations is 
pointed out in Fig. 3. The obtained graphs demonstrate a good applicability of the developed 
technique for the screening of milk samples. For accuracy control two certified reference 
materials with 0.111±0.018 µg kg
-1
 and 0.44±0.06 µg kg
-1 
of AfM1 were used and 0.093 µg 
kg
-1
 and 0.452 µg kg
-1
 of AfM1, respectively, were found by FLISA.  
The validation of on-site column tests was performed with a sterilized milk sample 
artificially spiked with AfM1. Standard solutions and artificially spiked milk samples with 
AfM1 concentrations equal to or more than the cut-off level resulted in no luminescence 
observation under a UV lamp. Inversely, standard solutions and artificially spiked milk 
samples with AfM1 concentrations less than 0.05 µg kg
-1 
resulted in bright luminescence 
under UV light (Fig.4). 
Performance parameters were calculated based on the summarized data of repeated 
experiments. The rates for false positive and false negative results were below 5% (2.6 % and 
3.3%, respectively) and the specificity and sensitivity rates were > 95 %, so according to 
Commission Decision 2002/657/EC [35]. 
 
Conclusion 
QD-loaded liposomes were used to detect an analytical signal in two different formats 
of immunosorbent assay: FLISA and non-instrumental qualitative column tests (gel-based and 
frit-based formats). Two different approaches for AfM1-protein conjugate preparation were 
evaluated and use of cBSA was found optimal. Direct addition of labeled conjugate in the 
analyzed samples was successfully applied and thereby the analysis procedure could be 
shortened and simplified. The cut-off values were aimed at the maximum level for AfM1 in 
milk products established by the European Commission (0.05 µg kg
-1
). Application of the 
QD-loaded liposomes allowed to reach the IC50 value in FLISA of 0.014 µg kg
-1 
and the cut-
off for both on-site formats of 0.05 µg kg
-1
. The developed ultra sensitive systems for 
aflatoxin M1 determination were tested and validated for rapid screening of milk products.  
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Fig. 1 FLISA calibration curves for aflatoxin M1 determination in standard solutions with 
different conjugates: AfB1-cBSA-LQD, AfM1-OVA-LQD, AfB1-OVA-LQD, AfM1-cBSA-
LQD (n=5). λex=380 nm, λem=590 nm. Analytical parameters are presented in the table (data 
indicate averages of fivefold determinations)
A. 
 




         0          0.005          0.01          0.012 µg kg
-1 
 
Fig. 2 Aflatoxin M1 detection by gel-based (A) and frit-based (B) column immunoassay. The 
cut–off for both formats was 0.01 µg kg
-1
 (for fivefold diluted milk samples)
 
  A.                                                                         B. 
.
 
Fig. 3 Linear regression equation derived using FLISA data for aflatoxin M1 screening in 




Fig. 4 Aflatoxin M1 determination in artificially spiked sterilized milk (A) and cream (B) 
samples by immunochemical on-site column tests (n=3). Results presented as:  
(yellow) or “-“ - luminescence presence of the detection immunolayer,  
              Aflatoxin M1 concentration < cut-off level, negative result; 
(white) or “+” - luminescence absence of the detection immunolayer,  
             Aflatoxin M1 concentration ≥ cut-off level, positive result   
  
 
